The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
Citation
Coulson, R, Liew, S, Connelly, A et al 2017, 'The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma', Oncotarget, vol. 8, no. 12, pp. 18640-18656pp.Year
2017ANU Authors
Fields of Research
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
- Cancer Cell Biology
- Molecular Targets